Immunology

New findings on autoimmune diseases, immunotherapies, and the body’s defense against pathogens: Research updates from the Department of Immunology at FAU Erlangen-Nürnberg.

9 total

07MAY 2026
FAU news
New approach to combat rejection after stem cell transplantation
FAU researchers aim to improve the diagnosis and treatment of both diseases
Read more about New approach to combat rejection after stem cell transplantation
24FEB 2026
FAU news
Why our immune system remembers vaccinations for decades
Study by FAU and Erlangen University Hospital shows: Metabolic rest is the key to long-lasting immunological memory
Read more about Why our immune system remembers vaccinations for decades
30JAN 2026
FAU news
Blood test to give insights into a person’s infection history
Researchers from FAU are investigating the immune system’s sensors
Read more about Blood test to give insights into a person’s infection history
20JAN 2026
FAU news
Hope for people with severe autoimmune diseases thanks to cell therapy in Erlangen
Results of the largest study in the world on the effectiveness of CAR-T cells in treating autoimmune diseases have now been published. For many people with severe autoimmune diseases, everyday life is marked by pain, exhaustion and taking medication in the long term. Diseases such as systemic lupus erythematosus, systemic sclerosis or autoimmune inflammatory muscle […]
Read more about Hope for people with severe autoimmune diseases thanks to cell therapy in Erlangen
10OCT 2025
FAU news
Killer cells How the immune system selects its defense troops
Researchers at FAU investigate fundamental biological process in immunized test persons If killer cells from the immune system encounter signs of an infection, some of them start to divide rapidly. They grow to become a large defense troop that then attacks the pathogen. However, that is not the case for each individual killer cell by […]
Read more about Killer cells How the immune system selects its defense troops
07OCT 2025
FAU news
CAR-T cell therapy treats severe bowel disease successfully for the first time
21 year old with therapy-resistant, severe inflammatory bowel disease treated successfully with cellular immune therapy A team of doctors from Deutsches Zentrum Immuntherapie at Uniklinikum Erlangen has succeeded for the first time in treating a young patient with a severe case of therapy-resistant inflammatory bowel disease (ulcerative colitis) with cell therapy using CD19-CAR-T cells. The […]
Read more about CAR-T cell therapy treats severe bowel disease successfully for the first time
20MAR 2025
FAU news
CAR-T cells: Gaining a better understanding of treating Lupus disease
Translational study funded with 600,000 US dollars. Uniklinikum Erlangen at Friedrich-Alexander-Universität Erlangen-Nürnberg has successfully treated more than 45 people with autoimmune diseases using a novel innovative therapy using CAR-T cells since 2021, including more than 15 patients with systemic lupus erythematosus. The patients, for whom no other treatments were successful, show no symptoms today. In […]Translational study funded with 600,000 US dollars. Uniklinikum Erlangen at Friedrich-Alexander-Universität Erlangen-Nürnberg has successfully treated more than 45 people with autoimmune diseases using a novel innovative therapy using CAR-T cells since 2021, including more than 15 patients with systemic lupus erythematosus. The patients, for whom no other treatments were successful, show no symptoms today. In […]
Read more about CAR-T cells: Gaining a better understanding of treating Lupus disease
16JUL 2024
FAU news
Hugely significant results for immunotherapy
FAU researchers use AI to develop cancer treatment Modern cancer immune therapies use the human immune system to fight cancer. Immune cells, in particular T cells, must be trained to recognize cancer cells and target them specifically. The team led by the physicist Prof. Dr. Julio Vera-González in the Laboratory of Systems Tumor Immunology at […]
Read more about Hugely significant results for immunotherapy
08JUL 2024
FAU news
World’s first CAR-T cell therapy for a child with lupus
“One year after the treatment, I feel as good as I did before my diagnosis, except for a few colds,” says Uresa A. today. In June 2023, Uresa (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), […]
Read more about World’s first CAR-T cell therapy for a child with lupus